FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. division BD Medical has launched a new prefillable glass syringe designed for biotech drugs.
The medical supplies manufacturer announced Monday the launch of BD Neopak, which it said was designed to address industry challenges in developing, manufacturing and marketing biologics to patients, saying it would provide a higher level of quality and enhanced container and device integration. The company noted that seven of the top-10 drugs worldwide and more than half the drugs in development were biologics.
"In today's environment, regulatory authorities, patients and prescribers demand higher-quality and more reliability in injectable drug delivery systems," BD Medical president of pharmaceutical systems Claude Dartiguelongue said. "The BD Neopak glass prefillable syringe is designed to reduce risks associated with primary container and drug interactions and enable our customers' drug products speed to market safely and effectively."